VAI VAI News

19 Feb 2020

‘Freedom Writers’ author to keynote VAI’s Science on the Grand conference

Posted Byalex

Comments0

GRAND RAPIDS, Mich. — Erin Gruwell, the New York Times best-selling author of “The Freedom Writers Diary,” will keynote the first day of Van Andel Institute for Education’s annual Science...

13 Feb 2020

$4.5 million co-funding agreement for Parkinson’s research announced

Posted Byalex

Comments0

TagsCure Parkinson’s Trust, Linked Clinical Trials (LCT), P. Brundin, Parkinson's disease

NOTE: This release was originally published by The Cure Parkinson’s Trust LONDON (Feb. 13, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to announce...

12 Feb 2020

Van Andel Institute’s Juan Du, Ph.D. awarded Sloan Research Fellowship

Posted Byalex

Comments0

TagsDu, structural biology, VARI

Two-year fellowship honors exemplary early career scientists GRAND RAPIDS, Mich. (Feb. 12, 2020) — The Alfred P. Sloan Foundation has named Van Andel Institute’s Juan Du, Ph.D., to its 2020...

4 Feb 2020

Dietary interventions may slow onset of inflammatory and autoimmune disorders

Posted Byalex

Comments0

Tagsautoimmune disorders, Eric Ma, inflammation, metabolism, russell jones, VARI

GRAND RAPIDS, Mich. (Feb. 4, 2020) — Significantly reducing dietary levels of the amino acid methionine could slow onset and progression of inflammatory and autoimmune disorders such as multiple sclerosis...

28 Jan 2020

VAI Chief Investment Officer Kathleen Vogelsang named to AACSB’s 2020 Class of Influential Leaders

Posted Byalex

Comments0

Tagsaward, Vogelsang

Grand Rapids, Mich. (Jan. 28, 2020) – Van Andel Institute Chief Investment Officer Kathleen Vogelsang has been named to the 2020 Class of Influential Leaders of the Association to Advance...

15 Jan 2020

New study may lead to fewer hysterectomies in women with uterine fibroid tumors

Posted Byalex

Comments0

Tagsbioinformatics, collaboration, Huihui Fan, Shen

NOTE: This release was originally published by Michigan State University College of Human Medicine. Uterine fibroid tumors are the leading cause of hysterectomies in the U.S., yet little is known...

13 Jan 2020

Phase II clinical trial of respiratory drug for treatment of Parkinson’s disease reveals promising results

Posted Byalex

Comments0

TagsCure Parkinson’s Trust, Linked Clinical Trials (LCT), P. Brundin, Parkinson's disease

NOTE: This release was originally published by The Cure Parkinson’s Trust. Results published today in the Journal of the American Medical Association (JAMA) Neurology The Cure Parkinson’s Trust (CPT) is...

News

ALL | BLOG | NEWS RELEASES | FEATURED STORIES | IN THE NEWS

‘Freedom Writers’ author to keynote VAI’s Science on the Grand conference

$4.5 million co-funding agreement for Parkinson’s research announced

Van Andel Institute’s Juan Du, Ph.D. awarded Sloan Research Fellowship

Dietary interventions may slow onset of inflammatory and autoimmune disorders

VAI Chief Investment Officer Kathleen Vogelsang named to AACSB’s 2020 Class of Influential Leaders

New study may lead to fewer hysterectomies in women with uterine fibroid tumors

Phase II clinical trial of respiratory drug for treatment of Parkinson’s disease reveals promising results

Archives

News

ALL | BLOG | NEWS RELEASES | FEATURED STORIES | IN THE NEWS

Archives

Tag Cloud